← back to search

Hongzhou Zhang

Nanchang University · CN
Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research focused on Myocardial infarction and Sacubitril, with related work in Microvesicles, Nomogram, Gene knockdown. Notable publications include 'Efficacy and Safety of Sacubitril-Valsartan in Heart Failure: A Meta-Analysis of Randomized Controlled Trials', 'Quantitative proteomics reveal three potential biomarkers for risk assessment of acute myocardial infarction', and 'A Clinical-Radiomic Nomogram Based on Unenhanced Computed Tomography for Predicting the Risk of Aldosterone-Producing Adenoma'.
h-index
citations
141
works
8
NIH funding
primary concept
email

Recent publications

Age at type 2 diabetes diagnosis and the risk of mortality among US population
Scientific Reports 2024cited by 11position: lastdoi
Quantitative proteomics reveal three potential biomarkers for risk assessment of acute myocardial infarction
Bioengineered 2022cited by 28position: middledoi
Colchicine may become a new cornerstone therapy for coronary artery disease: a meta‐analysis of randomized controlled trials
Clinical Rheumatology 2022cited by 14position: middledoi
Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials
Cardiovascular Drugs and Therapy 2022cited by 10position: middledoi
A Clinical-Radiomic Nomogram Based on Unenhanced Computed Tomography for Predicting the Risk of Aldosterone-Producing Adenoma
Frontiers in Oncology 2021cited by 19position: middledoi
Knockdown of ZFAS1 improved the cardiac function of myocardial infarction rats via regulating Wnt/β-catenin signaling pathway
Aging 2021cited by 14position: middledoi
Efficacy and Safety of Cilostazol for Atherosclerosis: A Meta-analysis of Randomized Controlled Trials
Journal of Cardiovascular Pharmacology 2021cited by 9position: middledoi
Efficacy and Safety of Sacubitril-Valsartan in Heart Failure: A Meta-Analysis of Randomized Controlled Trials
ESC Heart Failure 2020cited by 36position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Qinghua Wu · Nanchang University4 papers (2020–2022)Tieqiu Huang · Nanchang University4 papers (2020–2022)Pingping Yang · Nanchang University3 papers (2020–2022)Tao Wu · Hebei Medical University2 papers (2020–2021)Yanqing Wu · The First Affiliated Hospital, Sun Yat-sen University2 papers (2020–2022)Hongbing Wan · Nanchang University2 papers (2020–2021)Wen Shen · Nanchang University2 papers (2020–2022)Yi Chen · The First Affiliated Hospital, Sun Yat-sen University1 papers (2022–2022)Xiaomin Hu · University of Electronic Science and Technology of China1 papers (2021–2021)Yixi Wang · Nanchang University1 papers (2021–2021)Meng Li · Nanchang University1 papers (2022–2022)Jian Xiang · Nanchang University1 papers (2021–2021)Yang Fu · Nanchang University1 papers (2022–2022)Cong Xu · Qingdao University1 papers (2022–2022)Dan Wu · Nanchang University1 papers (2021–2021)Xiuxiu Xu · Nanchang University1 papers (2020–2020)Huasong Xia · Nanchang University1 papers (2022–2022)Hongjin Zhang · Nanchang University1 papers (2024–2024)Jie Feng · Nanchang University1 papers (2024–2024)Dan Zhu · Nanchang University1 papers (2020–2020)